Shell Asset Management CO Spectrum Pharmaceuticals Inc Transaction History

Shell Asset Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$1.27 - $2.42 $154,420 - $294,250	-121,591 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$2.15 - $3.82 $11,201 - $19,902	-5,210 Reduced 4.11%	121,591 $265,000
Q2 2021 Aug 12, 2021	BUY	$2.89 - $4.45 $19,767 - $30,438	6,840 Added 5.7%	126,801 $476,000
Q1 2021 May 10, 2021	BUY	$2.9 - $4.09 $347,886 - $490,640	119,961 New	119,961 $391,000
Q2 2019 Aug 12, 2019	SELL	$7.36 - $11.26 $126,474 - $193,491	-17,184 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$6.39 - $16.99 $8,946 - $23,785	-1,400 Reduced 7.53%	17,184 $150,000
Q3 2018 Nov 13, 2018	BUY	$16.52 - $24.82 $307,007 - $461,254	18,584 New	18,584 $312,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.